Error: Could not add to watchlist. X

Novogen Ltd

+ Watchlist
NVGN:US
NASDAQ CM
1.85
USD
0.04
2.12%
As of 3:59 PM EST on 2/11/2016.
Open
1.85
Day Range
1.83 - 1.88
Volume
43,674
Previous Close
1.89
52Wk Range
1.83 - 9.50
1 Yr Return
-29.39%
Open
1.85
Day Range
1.83 - 1.88
Volume
43,674
Previous Close
1.89
52Wk Range
1.83 - 9.50
1 Yr Return
-29.39%
YTD Return
-11.48%
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
31.628
Shares Outstanding (m)
17.189
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
ADDRESS
16 - 20 Edgeworth David Ave
Hornsby, NSW 2077
Australia
PHONE
61-2-9472-4100
Show More